Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer. uri icon

authors

  • Yang, Fan
  • Yuan, Chenyang
  • Chen, Fanghui
  • Qin, Zhaohui S
  • Nicole C. Schmitt, MD
  • Lesinski, Gregory B
  • Saba, Nabil F
  • Teng, Yong

publication date

  • March 12, 2024